The AdvaMed Medtech Conference was held September 26–28 in D.C. Drawing nearly 2000 executives from the medical device sector, the event featured a number of insightful presentations on topics ranging from the Affordable Care Act to VC funding. MD+DI editor Heather Thompson and a host of guest bloggers shared their take on our DeviceTalk blog. Below are some of highlights from the event:

• AdvaMed Leaders Stress the Importance of Innovation, FDA Reform, and Exports
• AdvaMed Panelists Take Stock of Affordable Care Act
• There Is More Opportunity than You Might Think in India
• MedTech 3.0 is About Nontraditional Partnerships and a Changing Customer Base
• For a Brighter Future, FDA and Industry Must Focus on Solutions
• One Thing’s for Certain: There’s a Lot of Uncertainty in Today’s Medtech Industry
• For a Brighter Future, FDA and Industry Must Focus on Solutions
• Pros and Cons to the Contract Manufacturing Agreement Process
• Conquering the 510(k) Mountain
• Growing Competition in Medtech Space More about Quality than Cost
• Trials, Tribulations, and Trends of Medical Device and Diagnostics Funding
• A New Era of Medtech Mergers, Acquisitions, and Strategic Alliances

*NEW

• The state of acquisitions in medtech [VIDEO]

—Brian Buntz

Featured Image: